Sign in Create account
Sign in and upgrade to a paid plan to export financials as CSV.

BOSTON COMMERCE LIMITED

Healthcare · Healthcare Services

BSE: 531458
₹9.64
▲ 0.45 (4.90%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
30/100
Weak
Valuation
97/100
Undervalued
Momentum
75/100
Bullish

QVM read Cheap and turning up Quality Weak, Valuation Undervalued, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹7 Cr
PE (TTM)
Data unavailable.
Price to Book
1.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-39.7
Free Cash Flow
₹-5 Cr
as of March 31, 2025
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-1377.14%
as of March 31, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
24.96%
as of March 31, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
-23.30%
as of March 31, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
73.08%
as of Dec. 31, 2025
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
1213.33%
as of Sept. 30, 2018
Industry median 18.84% (52 companies)
Current Ratio
2.07
as of March 31, 2025
Industry median 2.06 (74 companies)
Debt to Equity
0.92
as of March 31, 2025
Industry median 0.11 (62 companies)
Interest Coverage
0.02
as of March 31, 2026
Industry median 7.94 (57 companies)
Net Margin
-23.73%
as of Dec. 31, 2025
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
-23.73%
as of Dec. 31, 2025
Industry median 17.21% (61 companies)
Operating Margin (TTM)
1.81%
as of March 31, 2026
Industry median 16.20% (59 companies)
Return on Assets
-4.62%
as of March 31, 2025
Industry median 5.40% (58 companies)
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
-11.67%
as of March 31, 2025
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

0 of 3 met
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.92)
  • No Return on equity is 15% or more (-11.7%)

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

4 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
4.9%
Low 9.6200 · High 9.6400
1W return
27.0%
Low 7.9000 · High 9.6400
1M return
100.8%
Low 4.1000 · High 9.6400
52W return
-42.5%
Low 4.0100 · High 9.6400
Lifetime High ₹21.8500 (Dec. 5, 2014)
Lifetime Low ₹2.3100 (Jan. 4, 2013)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish5
Bearish1
5D
8.8
10D
8.0
20D
7.2
50D
7.7
100D
9.4
200D
12.3

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
95.6%
Month avg. delivery
94.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

9.63
Pivot
First resistance9.65
Second resistance9.65
Third resistance9.67
First support9.63
Second support9.61
Third support9.61
Day RSI74.5
Day MFI98.3
Day MACD0.63
Day MACD signal0.05

Beta

1M0.01
3M-0.66
1Y-0.66
3Y-0.66

Price change analysis

↑ 100.8%
Over 1 Month
LowHigh
4.109.64
↓ -42.5%
Over 3 Months
LowHigh
4.019.64
↓ -42.5%
Over 6 Months
LowHigh
4.019.64
↓ -42.5%
Over 1 Year
LowHigh
4.019.64
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (March 31, 2026)
₹— Cr
Net profit (March 31, 2026)
₹— Cr
Basic EPS (March 31, 2026)
₹-10.3400

Ranks #62 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter2.14%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 2.14% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 213 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
30 Sep 2026 NIKHIL GUPTA Bulk Buy 40,000 9.6400 BSE
28 Sep 2026 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 50,000 7.9400 BSE
28 Sep 2026 ARUNABEN AKSHY BAROT Bulk Buy 50,000 7.9400 BSE
18 Sep 2026 PRIYANKKUMAR ATULKUMAR DESAI HUF Bulk Buy 38,000 6.5300 BSE
18 Sep 2026 RITESH JITENDRA VASNAWALA Bulk Sell 59,000 6.5300 BSE
17 Sep 2026 RITESH JITENDRA VASNAWALA Bulk Buy 84,740 5.9800 BSE
3 Jul 2026 JUGAL MANGILAL KANUGO Bulk Sell 35,388 5.4600 BSE
17 Jun 2026 DIVYA KANDA Bulk Sell 69,037 5.4300 BSE
20 Jan 2026 MADHUSUDAN RAO POLINENI Bulk Buy 42,000 9.8900 BSE
20 Jan 2026 REETABEN ASHVINKUMAR SHUKLA Bulk Buy 44,000 9.8900 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Boston Bio Systems Ltd. to BOSTON COMMERCE LIMITED
—NAME_CHANGEName changed from LASER EYE CARE LTD. to Boston Bio Systems Ltd.

All corporate actions →

Corporate Announcements

All 8 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Boston Commerce Ltd - 531458 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Insider Trading / SAST Boston Commerce Ltd - 531458 - Closure of Trading Window
15 Sep 2026 Company Update Boston Commerce Ltd - 531458 - Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Sep 2026 Company Update Boston Commerce Ltd - 531458 - Letter To Shareholders Pursuant To Regulation 36(1)(B) Of The SEBI Listing Regulations
11 Sep 2026 Company Update Boston Commerce Ltd - 531458 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
11 Sep 2026 Corp. Action Boston Commerce Ltd - 531458 - Notice For Closure Of Transfer Books For 31St Annual General Meeting Of The Company.
11 Sep 2026 Others Boston Commerce Ltd - 531458 - Reg. 34 (1) Annual Report.
11 Sep 2026 Others Boston Commerce Ltd - 531458 - Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th September, 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 2.07)
  • Strong revenue growth YoY (1213.3%)

Weaknesses

  • Low Return on Equity (-11.7%)
  • Thin net profit margin (-23.7%)

Opportunities

Data unavailable.

Threats

  • RSI in overbought territory (74.5)
  • Down 42.5% over the past year
  • Weak interest coverage (0.0x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about BOSTON COMMERCE LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.